The emerging epigenetics of PARK7 and its implication in neurodegenerative disease

被引：0
|
作者：
Vavougios, George D. [1 ]
Zarogiannis, Sotirios G. [2 ]
机构：
[1] Athens Naval Hosp, Dept Neurol, Athens, Greece
[2] Univ Thessaly, Fac Med, Dept Physiol, Larisa, Greece
来源：
NEURAL REGENERATION RESEARCH | 2018年 / 13卷 / 09期
关键词：
MULTIPLE-SCLEROSIS; ACETYLATION; RECEPTOR; PROTEIN;
D O I：
10.4103/1673-5374.237117
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
引用
收藏
页码：1542 / 1543
页数：2
相关论文
共 50 条
  • [21] Genetics, environmental factors and the emerging role of epigenetics in neurodegenerative diseases
    Migliore, Lucia
    Coppede, Fabio
    MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 2009, 667 (1-2) : 82 - 97
  • [22] PARK7 protein translocating into spermatozoa mitochondria in Chinese asthenozoospermia
    Sun, Yi
    Zhang, Wen-Jia
    Zhao, Xin
    Yuan, Ren-Pei
    Jiang, Hui
    Pu, Xiao-Ping
    REPRODUCTION, 2014, 148 (03) : 249 - 257
  • [23] DJ-1 (PARK7) gene expression and interactors: implications for idiopathic Parkinson's disease
    Kumaran, R.
    Vandrovcova, J.
    Lees, A. J.
    Bandopadhyay, R.
    NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2009, 35 : 14 - 14
  • [24] PARK7/DJ-1 in microglia: implications in Parkinson’s disease and relevance as a therapeutic target
    Frida Lind-Holm Mogensen
    Andrea Scafidi
    Aurélie Poli
    Alessandro Michelucci
    Journal of Neuroinflammation, 20
  • [25] The expression of DJ-1 (PARK7) in normal human CNS and idiopathic Parkinson's disease
    Bandopadhyay, R
    Kingsbury, AE
    Cookson, MR
    Reid, AR
    Evans, IM
    Hope, AD
    Pittman, AM
    Lashley, T
    Canet-Aviles, R
    Miller, DW
    McLendon, C
    Strand, C
    Leonard, AJ
    Abou-Sleiman, PM
    Healy, DG
    Ariga, H
    Wood, NW
    de Silva, R
    Revesz, T
    Hardy, JA
    Lees, AJ
    BRAIN, 2004, 127 : 420 - 430
  • [26] Parkinson's disease protein PARK7 prevents metabolite and protein damage caused by a glycolytic metabolite
    Heremans, Isaac P.
    Caligiore, Francesco
    Gerin, Isabelle
    Bury, Marina
    Lutz, Marilena
    Graff, Julie
    Stroobant, Vincent
    Vertommen, Didier
    Teleman, Aurelio A.
    Van Schaftingen, Emile
    Bommer, Guido T.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2022, 119 (04)
  • [27] Generation of iPSC line from a Parkinson patient with PARK7 mutation and CRISPR-edited Gibco human episomal iPSC line to mimic PARK7 mutation
    Mazza, Melissa Conti
    Beilina, Alexandra
    Roosen, Dorien A.
    Hauser, David
    Cookson, Mark R.
    STEM CELL RESEARCH, 2021, 55
  • [28] PARK7/DJ-1 in microglia: implications in Parkinson's disease and relevance as a therapeutic target
    Lind-Holm Mogensen, Frida
    Scafidi, Andrea
    Poli, Aurelie
    Michelucci, Alessandro
    JOURNAL OF NEUROINFLAMMATION, 2023, 20 (01)
  • [29] Epigenetics in osteoarthritis and its implication for future therapeutics
    Im, Gun-Il
    Choi, You-Jeong
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2013, 13 (05) : 713 - 721
  • [30] Assessment of a DJ-1 (PARK7) polymorphism in Finnish PD
    Eerola, J
    Hernandez, D
    Launes, J
    Hellström, O
    Hague, S
    Gulick, C
    Johnson, J
    Peuralinna, T
    Hardy, J
    Tienari, PJ
    Singleton, AB
    NEUROLOGY, 2003, 61 (07) : 1000 - 1002
12345